<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>TB R&#38;D Matters Blog &#187; TB Drug Development</title>
	<atom:link href="http://www.newtbdrugs.org/blog/category/tb-drug-development/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.newtbdrugs.org/blog</link>
	<description>Working Towards a Faster Cure for Tuberculosis</description>
	<lastBuildDate>Wed, 15 May 2013 17:30:21 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>Tagline Spring 2013:  3 Articles on TB Research</title>
		<link>http://www.newtbdrugs.org/blog/tagline-spring-2013-3-articles-on-tb-research/</link>
		<comments>http://www.newtbdrugs.org/blog/tagline-spring-2013-3-articles-on-tb-research/#comments</comments>
		<pubDate>Fri, 26 Apr 2013 20:01:00 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Announcements]]></category>
		<category><![CDATA[TB Drug Development]]></category>
		<category><![CDATA[TB Pediatrics]]></category>
		<category><![CDATA[clinical trials]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[markets]]></category>
		<category><![CDATA[pediatric]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[TAG]]></category>
		<category><![CDATA[treatment]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=4290</guid>
		<description><![CDATA[Treatment Action Group (TAG) recently released its Spring 2013 issue of tagline, which contains three articles about TB research that might be of interest to you-- 1) on rifapentine research and access, 2) on adaptive clinical trial designs, and 3) on pediatric drug development needs. ]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/tagline-spring-2013-3-articles-on-tb-research/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TB Edition of The Lancet Infectious Diseases</title>
		<link>http://www.newtbdrugs.org/blog/tb-edition-of-the-lancet-infectious-diseases/</link>
		<comments>http://www.newtbdrugs.org/blog/tb-edition-of-the-lancet-infectious-diseases/#comments</comments>
		<pubDate>Wed, 27 Mar 2013 17:27:58 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Announcements]]></category>
		<category><![CDATA[TB Drug Development]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[TB Prevention and Control Strategies]]></category>
		<category><![CDATA[cptr]]></category>
		<category><![CDATA[crisis]]></category>
		<category><![CDATA[infectious diseases]]></category>
		<category><![CDATA[lancet]]></category>
		<category><![CDATA[mdr]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[stop tb]]></category>
		<category><![CDATA[stop tb partnership]]></category>
		<category><![CDATA[tb alliance]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=4272</guid>
		<description><![CDATA[To commemorate World TB Day 2013, The Lancet Infectious Diseases publishes a Series of papers on tuberculosis, a disease that has long plagued human beings and was declared a global emergency in 1993 by WHO. ]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/tb-edition-of-the-lancet-infectious-diseases/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Get Ready for World TB Day March 24, 2013!</title>
		<link>http://www.newtbdrugs.org/blog/get-ready-for-world-tb-day-march-24-2013/</link>
		<comments>http://www.newtbdrugs.org/blog/get-ready-for-world-tb-day-march-24-2013/#comments</comments>
		<pubDate>Wed, 20 Mar 2013 21:19:29 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Announcements]]></category>
		<category><![CDATA[Events]]></category>
		<category><![CDATA[TB Drug Development]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[TB Prevention and Control Strategies]]></category>
		<category><![CDATA[advocacy]]></category>
		<category><![CDATA[community]]></category>
		<category><![CDATA[funding]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[march 24]]></category>
		<category><![CDATA[mdr]]></category>
		<category><![CDATA[pediatric]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[stigma]]></category>
		<category><![CDATA[stop tb]]></category>
		<category><![CDATA[stop tb partnership]]></category>
		<category><![CDATA[tb alliance]]></category>
		<category><![CDATA[the union]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[wgnd]]></category>
		<category><![CDATA[WHO]]></category>
		<category><![CDATA[world tb day]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=4256</guid>
		<description><![CDATA[World TB Day is celebrated on March 24 and there is a lot going on during this week and next to highlight the continued problem of TB in the world and the solutions to address the problem. Included is a list of publications, news items, events, and links related to TB and World TB Day 2013.  ]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/get-ready-for-world-tb-day-march-24-2013/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Bedaquiline Receives Accelerated Approval from the FDA for MDR-TB Rx</title>
		<link>http://www.newtbdrugs.org/blog/bedaquiline-receives-accelerated-approval-from-the-fda-for-mdr-tb-rx/</link>
		<comments>http://www.newtbdrugs.org/blog/bedaquiline-receives-accelerated-approval-from-the-fda-for-mdr-tb-rx/#comments</comments>
		<pubDate>Mon, 07 Jan 2013 02:34:41 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Announcements]]></category>
		<category><![CDATA[Regulations and Guidelines]]></category>
		<category><![CDATA[TB Drug Development]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[fda]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[janssen]]></category>
		<category><![CDATA[johnson and johnson]]></category>
		<category><![CDATA[markets]]></category>
		<category><![CDATA[mdr]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[treatment]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=4235</guid>
		<description><![CDATA[The FDA granted Janssen's TB drug Bedaquiline accelerated approval for treatment of MDR-TB.  A link is provided to the FDA press release and Janssen's full press release is included.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/bedaquiline-receives-accelerated-approval-from-the-fda-for-mdr-tb-rx/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Advisory Committee recommends Janssen&#8217;s Bedaquiline for accelerated approval</title>
		<link>http://www.newtbdrugs.org/blog/fda-advisory-committee-recommends-janssens-bedaquiline-for-accelerated-approval/</link>
		<comments>http://www.newtbdrugs.org/blog/fda-advisory-committee-recommends-janssens-bedaquiline-for-accelerated-approval/#comments</comments>
		<pubDate>Thu, 29 Nov 2012 18:16:40 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[market access]]></category>
		<category><![CDATA[Regulations and Guidelines]]></category>
		<category><![CDATA[TB Drug Development]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[bedaquiline]]></category>
		<category><![CDATA[fda]]></category>
		<category><![CDATA[janssen]]></category>
		<category><![CDATA[johnson & johnson]]></category>
		<category><![CDATA[mdr]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[TMC-207]]></category>
		<category><![CDATA[treatment]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=4213</guid>
		<description><![CDATA[Yesterday, Nov. 28th, the FDA Ant-infective Drug Advisory Committee voted to recommend Janssen's Bedaquiline for accelerated approval for the treatment of MDR tuberculosis. A summary of the proceedings is included.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/fda-advisory-committee-recommends-janssens-bedaquiline-for-accelerated-approval/feed/</wfw:commentRss>
		<slash:comments>4</slash:comments>
		</item>
		<item>
		<title>Recap from the 43rd Union World Conference in Kuala Lumpur</title>
		<link>http://www.newtbdrugs.org/blog/recap-from-the-43rd-union-world-conference-in-kuala-lumpur/</link>
		<comments>http://www.newtbdrugs.org/blog/recap-from-the-43rd-union-world-conference-in-kuala-lumpur/#comments</comments>
		<pubDate>Tue, 27 Nov 2012 20:06:37 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Events]]></category>
		<category><![CDATA[TB Drug Development]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[TB Treatment]]></category>
		<category><![CDATA[advocacy]]></category>
		<category><![CDATA[biomarkers]]></category>
		<category><![CDATA[children]]></category>
		<category><![CDATA[clinical trials]]></category>
		<category><![CDATA[funding]]></category>
		<category><![CDATA[mdr]]></category>
		<category><![CDATA[pediatric]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[stop tb]]></category>
		<category><![CDATA[stop tb partnership]]></category>
		<category><![CDATA[TAG]]></category>
		<category><![CDATA[the union]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=4201</guid>
		<description><![CDATA[The week of November 12th was exciting with the 43rd Union World Conference, the WGND Annual Meeting (will be posting presentations soon), and the Stop TB Coordinating Board Meeting.  Included are some news highlights and a listing of webcasts of interesting and presentations relevant for TB drug development and research.  ]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/recap-from-the-43rd-union-world-conference-in-kuala-lumpur/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Growing Landscape of TB Trials:  Interview with Dr. Andrew Vernon</title>
		<link>http://www.newtbdrugs.org/blog/the-growing-landscape-of-tb-trials-interview-with-dr-andrew-vernon/</link>
		<comments>http://www.newtbdrugs.org/blog/the-growing-landscape-of-tb-trials-interview-with-dr-andrew-vernon/#comments</comments>
		<pubDate>Mon, 22 Oct 2012 15:27:57 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[TB Drug Development]]></category>
		<category><![CDATA[Video]]></category>
		<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[cdc]]></category>
		<category><![CDATA[clinical trials]]></category>
		<category><![CDATA[tbtc]]></category>
		<category><![CDATA[the union]]></category>
		<category><![CDATA[voices]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=4172</guid>
		<description><![CDATA[This week we highlight an interview with Dr. Andrew Vernon, the Chief, Clinical Research Branch, Division of Tuberculosis Elimination at the U.S. Centers for Disease Control and Prevention (CDC).   He discusses the progress made in TB drug development and the growing number of TB trials and trials groups.  ]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/the-growing-landscape-of-tb-trials-interview-with-dr-andrew-vernon/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Launch of the Good Participatory Practice Guidelines for TB Drug Trials</title>
		<link>http://www.newtbdrugs.org/blog/launch-of-the-good-participatory-practice-guidelines-for-tb-drug-trials/</link>
		<comments>http://www.newtbdrugs.org/blog/launch-of-the-good-participatory-practice-guidelines-for-tb-drug-trials/#comments</comments>
		<pubDate>Fri, 05 Oct 2012 19:44:30 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Action]]></category>
		<category><![CDATA[Announcements]]></category>
		<category><![CDATA[Regulations and Guidelines]]></category>
		<category><![CDATA[TB Drug Development]]></category>
		<category><![CDATA[clinical trials]]></category>
		<category><![CDATA[community]]></category>
		<category><![CDATA[community engagement]]></category>
		<category><![CDATA[cptr]]></category>
		<category><![CDATA[pharma]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[stakeholders]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=4164</guid>
		<description><![CDATA[The Stakeholder and Community Engagement Workgroup of the Critical Path to TB Drug Regimens initiative launches guidelines that will facilitate the involvement of communities and participants in the conduct of TB drug trials.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/launch-of-the-good-participatory-practice-guidelines-for-tb-drug-trials/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Live Streaming of Demystifying Pyrazinamide Workshop&#8211;September 5 &amp; 6</title>
		<link>http://www.newtbdrugs.org/blog/live-streaming-of-demystifying-pyrazinamide-workshop-september-5-6/</link>
		<comments>http://www.newtbdrugs.org/blog/live-streaming-of-demystifying-pyrazinamide-workshop-september-5-6/#comments</comments>
		<pubDate>Wed, 29 Aug 2012 18:30:14 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Events]]></category>
		<category><![CDATA[Front Lines of TB R&D]]></category>
		<category><![CDATA[TB Drug Development]]></category>
		<category><![CDATA[diagnostics]]></category>
		<category><![CDATA[drug discovery]]></category>
		<category><![CDATA[gates foundation]]></category>
		<category><![CDATA[JHU]]></category>
		<category><![CDATA[nih/niaid]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[stop tb partnership]]></category>
		<category><![CDATA[Video]]></category>
		<category><![CDATA[workshop]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=4133</guid>
		<description><![CDATA[On September 5 and 6, 2012, the "Demystifying Pyrazinamide – Challenges and Opportunities" Workshop will be held at Johns Hopkins University and is sponsored by National Institute of Allergy and Infectious Diseases, Bill and Melinda Gates Foundation, Johns Hopkins University Center for AIDS Research, and the Stop TB Partnership Working Group on New Drugs.  There will be live streaming available. ]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/live-streaming-of-demystifying-pyrazinamide-workshop-september-5-6/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>2012 WGND Annual Meeting is Nov 14 in Kuala Lumpur</title>
		<link>http://www.newtbdrugs.org/blog/save-the-date-2012-wgnd-annual-meeting-is-nov-14-in-kuala-lumpur/</link>
		<comments>http://www.newtbdrugs.org/blog/save-the-date-2012-wgnd-annual-meeting-is-nov-14-in-kuala-lumpur/#comments</comments>
		<pubDate>Wed, 15 Aug 2012 14:04:27 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Announcements]]></category>
		<category><![CDATA[Events]]></category>
		<category><![CDATA[TB Drug Development]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[clinical trials]]></category>
		<category><![CDATA[drug discovery]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[new tb drugs]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[stop tb]]></category>
		<category><![CDATA[stop tb partnership]]></category>
		<category><![CDATA[targets]]></category>
		<category><![CDATA[the union]]></category>
		<category><![CDATA[wgnd]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=4108</guid>
		<description><![CDATA[We will have our 2012 Annual Meeting in Kuala, Lumpur on <strong>Wednesday, November 14</strong> at the Impiana KLCC Hotel from 13:00 to 17:30. The meeting will be held in conjunction with the 43rd Union World Conference on Lung Health.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/save-the-date-2012-wgnd-annual-meeting-is-nov-14-in-kuala-lumpur/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
